Clinical Trial Update: Iron Supplement in the Prevention of Anemia in Female Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating iron supplementation to prevent anemia in female breast cancer patients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Ferrous sulfate (ferrous sulfate)

Snippet

Sponsor: Instituto do Cancer do Estado de São Paulo | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN